Insulin Resistance Study
Public ClinicalTrials.gov record NCT00614757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Prevalence of Insulin Resistance and the Potential Modulation of Insulin Resistance by N-acetylcysteine (NAC) in Patients Chronically Infected by the Hepatitis C Virus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate how often patients with hepatitis C infection have abnormalities of sugar and fat utilization. Additionally we would like to find out if these abnormalities of sugar and fat utilization are common in other liver diseases, or related to being overweight.
Study identification
- NCT ID
- NCT00614757
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2005
- Primary completion
- Nov 30, 2013
- Completion
- Nov 30, 2013
- Last update posted
- Oct 25, 2012
2005 – 2013
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kansas City VA Medical Center | Kansas City | Missouri | 64128 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Insulin Resistance trials
Other public records listing Insulin Resistance. Sorted by last update posted; newest first. Not a recommendation.
- NCT07778524: Alpelisib Challenge Test (ACT) Not yet recruiting
- NCT07653464: Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity Not yet recruiting
- NCT07724522: Prebiotic Inulin for Late-Reproductive Individuals Recruiting
- NCT05933707: Small Extracellular Vesicles and Insulin Action Recruiting
- NCT06007404: Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents Recruiting
- NCT07403604: Effect of Insulin Lowering on Lipogenesis Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00614757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2012 · Synced Sep 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00614757 live on ClinicalTrials.gov.